申请人:Syntex (U.S.A.) Inc.
公开号:US04496577A1
公开(公告)日:1985-01-29
This invention relates to novel imidazolidinone prostaglandin compounds of the formula ##STR1## and the pharmaceutically acceptable salts thereof, wherein R.sup.1 and R.sup.2 are independently hydrogen or alkyl of 1 to 4 carbons; R.sup.3 is hydrogen or methyl; and R4 is --(CH.sub.2).sub.n CH.sub.3 wherein n is 3-7, cycloalkyl of 5-7 carbons, a substituent of the formula ##STR2## wherein R.sup.5 is hydrogen, alkyl of 1 to 4 carbons, alkoxy of 1 to 4 carbons, halo or trifluoromethyl. These compounds are inhibitors of blood platelet aggregation.
本发明涉及新型咪唑啉酮前列腺素化合物的公式为##STR1##和其药学上可接受的盐,其中R1和R2分别为氢或1至4个碳的烷基;R3为氢或甲基;R4为--(CH2)nCH3,其中n为3-7,5-7个碳的环烷基,或取代基的公式##STR2##其中R5为氢,1至4个碳的烷基,1至4个碳的烷氧基,卤素或三氟甲基。这些化合物是血小板聚集抑制剂。